Blue Cross and Blue Shield Association opposes reduction in reimbursements to private Medicare Advantage plans

Alissa Fox, vice president of legislative and regulatory policy for the Blue Cross and Blue Shield Association, on Friday said that additional reductions in reimbursements to private Medicare Advantage plans "would be a disaster" for the program, CQ HealthBeat reports.

At a press briefing, Fox said that CMS has reduced reimbursements to MA plans by $13 billion over the past two years (Crowley, CQ HealthBeat, 2/2).

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) has said that he will seek to reduce reimbursements to private Medicare Advantage plans to help cover the cost of other health care proposals.

In response, BCBSA "stressed the program's value to low-income and minority beneficiaries, as well as residents of rural areas," CongressDaily reports.

In addition to reimbursements to MA plans, BCBSA identified SCHIP reauthorization and implementation of health care information technology as top legislative priorities for 2007.

BCBSA also raised some concerns about the health insurance proposal announced by President Bush during his State of the Union address.

Fox said, "We want to make sure there are incentives to build upon the employer-based system" (Lee, CongressDaily, 2/2).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vial size could save Medicare millions on Alzheimer's drug